mergers
2015’s top five mergers and acquisitions in a record-breaking year
October 19, 2015Sales and Marketing Deals, acquisitions, mergers, pharma, takeovers
A new report from analysts MergerMarket reveals that mergers and acquisitions so far in 2015 have surpassed the same 2014 …
Mylan to relaunch $27.1bn hostile takeover of Perrigo
September 10, 2015Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover
Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …
Shire goes public with rejected $30bn Baxalta bid
August 5, 2015Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease
Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …
Celgene to acquire Receptos in $7.2bn deal
July 15, 2015Sales and Marketing Celgene, Crohn's, Crohn’s disease, Receptos, acquisitions, crohn's disease, mergers, multiple sclerosis, ozanimod, relapsing multiple sclerosis, ulcerative colitis
Celgene has boosted its immune and inflammatory disease pipeline with the purchase of the biopharma company Receptos for $7.2 billion. …
Pharma dominates global M&A activity
July 10, 2015Sales and Marketing M&A, MA, acquisitions, mergers, takeovers
Mergers and acquisitions in the pharma, medical and biotech sectors have hit the highest levels in nearly 15 years, a …
Horizon attempts a hostile $3bn Depomed takeover
July 9, 2015Manufacturing and Production, Research and Development, Sales and Marketing Depomed, M&A, MA, acquisitions, horizon, mergers, takeover
Dublin-based specialty pharmaceutical company Horizon has launched a bid to buy Depomed for $3 billion. Horizon, a biopharma company focussed …
Valeant to buy Salix in $14.5 billion move
February 23, 2015Sales and Marketing Deals, Heptares, Valeant, mergers, salix, sosei
Valeant has agreed a deal to acquire US-based speciality manufacturer of gastrointestinal drugs Salix in a move worth around $14.5 …
AbbVie reconsiders Shire deal over tax laws
October 15, 2014Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax
AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …
Boehringer to slash 600 jobs in native Germany
September 24, 2014Manufacturing and Production, Research and Development, Sales and Marketing AMNOG, Boehringer, Germany, Novartis, cuts, mergers, staff
Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …
Hold your horses: M&A is about talent, not just pipelines
November 25, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, mergers, molloy, roik, rsa, talent
The morning mist is rising on the battlefield. At stake: the crown riches and glory of tomorrow’s pharma leadership. The …
Pressure on pharma M&A
January 7, 2013Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers
The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …
